Concepedia

Publication | Closed Access

Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?

30

Citations

29

References

2014

Year

Abstract

Basiliximab induction prevents acute rejection; however, it is associated with increased risk of NODAT.

References

YearCitations

Page 1